Australian Pharmaceutical Industries’s $127.4 million Acquisition of Clearskincare brand’s clinic and products businesses

Allens has advised the founders of Clearskincare on the sale Under the deal, API will take an initial 50.1 per cent stake in Clearskincare’s clinic business...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here